文献速递乳腺癌放疗放疗物理与技术

磁共振引导立体定向加速部分乳腺照射的实施

Implementing stereotactic accelerated partial breast irradiation using magnetic resonance guided radiation therapy.
PubMed 文献 · Radiother Oncol · 2021-10-06

本文介绍了基于磁共振引导放疗(MRgRT)的立体定向加速部分乳腺照射(MRgS-APBI)项目的开发与实施,涵盖两项前瞻性非随机I/II期临床试验(20Gy×1和8.5Gy×3)的放疗计划与MRgRT实施技术。研究分析了48例单次和19例三次分割患者的剂量学数据,结果显示88.5%的剂量学目标在计划阶段达成,平均摆位误差为1.0 cm±0.6 cm,三次分割试验中MRI门控束流占空比为83.0±13.0%,且无技术相关问题导致治疗中断。结论认为采用MR引导实施SBRT式剂量学和照射用于APBI是可行的。

要点

  • MRgS-APBI采用20Gy×1或8.5Gy×3的SBRT式分割方案,利用MRI软组织对比降低摆位不确定性。
  • 联合分析中88.5%的剂量学目标在计划阶段达成,多数目标易于实现,提示后续可设定更严格目标。
  • 平均摆位误差为1.0 cm±0.6 cm,三次分割试验中MRI门控平均束流占空比为83.0±13.0%。

核心结论

  • 采用MR引导实施SBRT式剂量学和照射用于APBI是可行的。
  • 本项目开发经验和剂量学结果可为其他机构临床实施MRgS-APBI提供参考。

研究设计与样本

  • 本研究为两项前瞻性非随机I/II期临床试验(20Gy×1和8.5Gy×3)的项目开发与实施描述。
  • 模拟定位包括CT和MRI,采用专用固定装置以适应MR引导摆位和 cine-MRI 治疗门控。
  • 收集并评估了48例单次分割和19例三次分割患者的剂量学数据,包括计划目标和SBRT特异性指标。
  • 治疗过程中计算摆位误差以评估摆位重复性,并利用门控照射期间的 cine-MRI 数据计算占空比。

主要发现

  • 单次和三次分割试验合并分析中,所有患者可能达到的剂量学目标有88.5%在计划阶段达成。
  • 多数计划目标易于实现,提示后续S-APBI治疗可设定更严格的目标。
  • 所有治疗的平均摆位不确定性幅度为1.0 cm±0.6 cm。
  • 三次分割试验中MRI门控照射的平均束流占空比为83.0±13.0%。
  • 所有患者中未出现导致治疗中止的MRgS-APBI相关技术问题。

关键数值与推荐

  • 两项试验的分割方案分别为20Gy×1和8.5Gy×3。
  • 联合分析中88.5%的剂量学目标在计划阶段达成。
  • 平均摆位误差为1.0 cm±0.6 cm。
  • 三次分割试验中MRI门控平均束流占空比为83.0±13.0%。

临床怎么用

  • MRgS-APBI可利用MRI软组织对比降低摆位不确定性,从而在外照射中减少 margins。
  • 采用SBRT式高梯度分割方案可减少分割次数并更多保护健康组织。
  • 本项目开发流程和剂量学结果可作为其他机构实施MRgS-APBI的参考。

局限性

  • 本文未报告长期临床结局(如局部控制率、生存率、不良反应)。
  • 研究为两项前瞻性非随机I/II期试验的项目描述,样本量有限(48例单次和19例三次分割)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Accelerated partial breast irradiation (APBI) seeks to reduce irradiated volumes and radiation exposure for patients while maintaining acceptable clinical outcomes. Magnetic resonance image-guided radiotherapy (MRgRT) provides excellent soft-tissue contrast for treatment localization, which can reduce setup uncertainty, thus reducing margins in the external beam setting. Additionally, stereotactic body radiotherapy (SBRT)-style regimens with high gradients can also be executed. This MR-guided stereotactic APBI (MRgS-APBI) approach can be utilized for a lower number of fractions and spare a greater volume of healthy tissues compared to conventional 3D external beam APBI. METHODS: Our MRgS-APBI program was developed for two prospective non-randomized phase I/II clinical trials (20Gyx1 and 8.5Gyx3). Both breast SBRT treatment planning and MRgRT delivery techniques were described in this study. Simulation included both CT and MRI with specialized immobilization to accommodate MR-guided setup and cine-MRI treatment gating. Dosimetry data from 48 single-fraction and 19 three-fraction patients were collected and evaluated. This included planning objectives and SBRT-specific indices. During treatment, setup errors were calculated to evaluate setup reproducibility and duty cycle was calculated using cine-MRI data during gated delivery. RESULTS: In both the single- and three- fraction trials combined, 88.5% of the possible dosimetric objectives across all patients were met during planning. The majority of the planning objectives were easily achievable indicating the potential for stricter objectives for subsequent S-APBI treatments. The average magnitude of setup uncertainties was 1.0 cm ± 0.6 cm across all treatments. In the three-fraction trial, the average beam-on duty-cycle for the MRI-gated delivery was 83.0 ± 13.0%. There were no technical MRgS-APBI related issues that resulted in discontinuation of treatment across all patients. CONCLUSION: SBRT-style dosimetry and delivery for APBI is feasible using MR-guidance. The program development and dosimetric outcomes reported here can serve as a guide for other institutions considering the clinical implementation of MR-guided stereotactic APBI.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Price AT, Kennedy WR, Henke LE, et al. Implementing stereotactic accelerated partial breast irradiation using magnetic resonance guided radiation therapy. Radiother Oncol. 2021. PMID: 34624406. doi:10.1016/j.radonc.2021.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。